$1.05
-0.08-7.08%
At close: May 14, 5:00 PM EST
$1.03
-0.1-8.85%
Pre-Market: 4:33 AM EST
Rein Therapeutics Inc Earnings Estimates
RNTXNASDAQ
Earnings: Q1 2026 Earnings were released on Fri May 15th, before the market open
Rein Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:RNTX
Rein Therapeutics (RNTX) is scheduled to report Q2 earnings on August 13, 2026. Analysts estimate EPS of $-0.49 and quarterly revenue of N/A.
In the most recent quarter (Q1), Rein Therapeutics reported EPS of $-0.19, beating estimates of $-0.49 by 0.61%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.
Rein Therapeutics has beaten EPS estimates in 3 consecutive quarters.
Over the last 4 quarters, Rein Therapeutics has averaged an EPS surprise of 0.38% and a revenue surprise of 0.00%.
Earnings Date
Aug 13
EPS Estimate
$-0.490
Quarterly Revenue Estimate
–
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Rein Therapeutics Earnings History
Analyze the earnings history of Rein Therapeutics using advanced sorting and filters.
Loading calendar...
Rein Therapeutics (RNTX) Earnings Per Share
The chart below shows Rein Therapeutics's reported EPS compared to analyst estimates over recent quarters.
Rein Therapeutics (RNTX) Revenue
The chart below shows Rein Therapeutics's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Rein Therapeutics (NASDAQ:RNTX) reporting earnings?
Rein Therapeutics (RNTX) is scheduled to report earnings on August 13, 2026. The last reported earnings were for reported on May 15, 2026 for Q1.
What were the latest earnings per share (EPS) for Rein Therapeutics (NASDAQ:RNTX)?
The Actual EPS was $-0.19, which beat the estimate of $-0.49.
What were Rein Therapeutics’s (NASDAQ:RNTX) revenues?
The Actual Revenue was $0.00, which hit the estimate of $0.00.
